A Pioneer Review on Lactoferrin-Conjugated Extracellular Nanovesicles for Targeting Cellular Melanoma: Recent Advancements and Future Prospects
ASSAY and Drug Development Technologies · 01.03.2025 · 23 (2) · 55-69
DOI: 10.1089/adt.2024.045 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ASSAY and Drug Development Technologies, erschienen am 01.03.2025. Verfasst von Dilpreet Singh und 1 weiteren Autor:innen. Beteiligte Einrichtung: University Institute of Pharma Sciences, Chandigarh University, Mohali, Punjab, India. Hauptthemen laut MEDLINE: Lactoferrin, Melanoma, Antineoplastic Agents, Extracellular Vesicles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 96 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University Institute of Pharma Sciences, Chandigarh University, Mohali, Punjab, India.
- University Centre for Research and Development, Chandigarh University, Mohali, Punjab, India.
ORCID-Profile: Dilpreet Singh
Zitieren
APA
Singh, D., & Prasad, S. (2025). A Pioneer Review on Lactoferrin-Conjugated Extracellular Nanovesicles for Targeting Cellular Melanoma: Recent Advancements and Future Prospects. ASSAY and Drug Development Technologies, 23(2), 55-69. https://doi.org/10.1089/adt.2024.045
Vancouver
Singh D, Prasad S. A Pioneer Review on Lactoferrin-Conjugated Extracellular Nanovesicles for Targeting Cellular Melanoma: Recent Advancements and Future Prospects. ASSAY and Drug Development Technologies. 2025;23(2):55-69. doi:10.1089/adt.2024.045
BibTeX
@article{Singh2025,
author = {Singh, Dilpreet and Prasad, Sonima},
title = {A Pioneer Review on Lactoferrin-Conjugated Extracellular Nanovesicles for Targeting Cellular Melanoma: Recent Advancements and Future Prospects},
journal = {ASSAY and Drug Development Technologies},
year = {2025},
volume = {23},
number = {2},
pages = {55--69},
doi = {10.1089/adt.2024.045}
}
EUVIMED